CompletedPhase 4

Phase 4 Study Evaluating the Safety of the Nasal Guide With Tyrvaya

United States30 participantsStarted 2023-06-14

Plain-language summary

The objective of this study is to determine the safety of the nasal guide when utilized to aid in the administration of Tyrvaya (varenicline solution 0.03mg) Nasal Spray

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Be at least 18 years of age
✓. Have provided verbal and written informed consent
✓. Willing to comply with all study related visits and procedures

What they're measuring

Number of Participants With Adverse Events

Timeframe: 7 days

Trial details

NCT IDNCT05918406

SponsorOyster Point Pharma, Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2023-08-18

Results submitted2025-03-24

View on ClinicalTrials.gov More Dry Eye trials